Biktarvy
Biktarvy is a pharmaceutical drug with 12 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.5%
7 of 8 finished
12.5%
1 ended early
1
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Late Presenter Treatment Optimisation Study
INSTI's For The Management of HIV-associated TB
Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity Settings in France -IMEA073
How Does Antiretroviral Therapy Affect Coronary Atherosclerosis: a Serial CT Study
Antiretroviral Speed Access Program
Clinical Trials (12)
The Late Presenter Treatment Optimisation Study
INSTI's For The Management of HIV-associated TB
Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity Settings in France -IMEA073
How Does Antiretroviral Therapy Affect Coronary Atherosclerosis: a Serial CT Study
Antiretroviral Speed Access Program
Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'
Effect of Biktarvy & Symtuza on microRNAs in HIV and Correlation With Weight Gain
A Test and Treat Strategy in New HIV Diagnosis.
Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens
Effects of Biktarvy on CFR in Stable HIV Patients
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12